Researchers reported an association with increased health care costs when the Veterans Health Administration (VHA) formulary transitioned from budesonide-formoterol metered-dose inhalers to uticasone-salmeterol dry-powder inhalers.

APhA staff

An analysis published June 24, 2025, in The Lancet suggests the Immunization Agenda 2030—the WHO’s campaign to bolster global childhood vaccination rates—will not achieve its goals in the next 5 years.

APhA staff

Long-standing, persistent shortages account for more than 90% of all drug shortages in the United States, according to the latest USP Annual Drug Shortages Report. Current shortages now last more than 4 years, up from about 3 years in 2023

APhA staff

Findings from a study published May 3, 2025, in The Lancet demonstrate that oral gepotidacin is a noninferior and safe alternative to ceftriaxone plus azithromycin for uncomplicated urogenital gonorrhea.

APhA staff

Dismissing patient, family, and caregiver concerns is the biggest threat to patient safety, according to ECRI. The organization said that time and resource constraints are making it increasingly difficult for health care providers to address patient concerns.

APhA staff